FOR PATIENTS · SOURCE READING
Childhood Hodgkin lymphoma is treated according to risk groups.
Source: Childhood Hodgkin Lymphoma Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 8, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Untreated childhood Hodgkin lymphoma is divided into risk groups based on the stage, size of the tumor, and whether the patient has B symptoms (fever, weight loss, or drenching night sweats). The risk group describes the likelihood that Hodgkin lymphoma will not respond to treatment or recur (come back) after treatment. It is used to plan initial treatment.
Source links and citations
Low-risk childhood Hodgkin lymphoma.
Source links and citations
Intermediate-risk childhood Hodgkin lymphoma.
Source links and citations
High-risk childhood Hodgkin lymphoma.
Source links and citations
Low-risk Hodgkin lymphoma requires fewer cycles of treatment, fewer anticancer drugs, and lower doses of anticancer drugs than high-risk lymphoma.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle